Biotechnology Sovereign Genomic Infrastructure Law In Russia.

1. Introduction

Biotechnology Sovereign Genomic Infrastructure Law in Russia concerns the legal framework through which the Russian Federation develops, controls, protects and manages its national genomic resources, genetic-information databases, DNA repositories, biotechnology research facilities and genomic data-processing infrastructure.

The concept of sovereign genomic infrastructure refers to a country's ability to maintain legal, scientific, technological and institutional control over its genomic information and associated biological resources.

In Russia, this subject is governed by several interconnected areas of law:

State genomic registration and DNA databases.

Genetic-information ownership and governmental control.

Personal-data protection and genomic privacy.

National genetic-information databases.

Biological sample collection and preservation.

Biotechnology research and genetic engineering.

Cybersecurity and information sovereignty.

International cooperation and cross-border genetic-data transfers.

National security and biosecurity.

Judicial protection against unlawful collection, disclosure or use of genetic information.

Important legal distinction: Russia does not have one comprehensive statute formally entitled the Sovereign Genomic Infrastructure Law. Rather, the subject is regulated through several federal laws, government institutions and information-governance mechanisms.

The central statutory foundation is Federal Law No. 242-FZ of 3 December 2008, concerning State Genomic Registration in the Russian Federation.

CIS Legislation+1

 

2. Constitutional foundations

The Russian Constitution provides the foundation for governmental control of genomic infrastructure while also protecting individual rights.

Constitutional provisionLegal significance
Article 21Human dignity and protection against degrading treatment
Article 23Privacy and personal and family secrets
Article 24Restrictions on collecting, storing and disseminating private information without lawful grounds
Article 41Right to health and medical assistance
Article 44Freedom of scientific and creative activity
Article 46Judicial protection of rights and freedoms
Article 55Conditions and constitutional limits on restricting individual rights

These provisions create two important legal responsibilities:

The state may develop national genomic infrastructure for legitimate public purposes, including scientific development, healthcare and national security.

Government institutions must respect privacy, confidentiality, legality and proportionality when collecting and processing individual genetic information.

Legal principle: National genomic sovereignty does not automatically give the government unrestricted ownership or use of every citizen's genetic identity.

3. Federal Law No. 643-FZ of 29 December 2022

Central legislation

One of the most important developments in Russian genomic infrastructure is Federal Law No. 643-FZ of 29 December 2022.

This law amended Federal Law No. 86-FZ of 5 July 1996, concerning State Regulation in the Field of Genetic Engineering Activities.

It introduced the statutory framework for the State Information System known as the National Database of Genetic Information (Национальная база генетической информации).

The legislation became effective on 1 September 2024.

CIS Legislation+2

 

A. Article 10.1 – National Database of Genetic Information

Article 10.1 provides for a national government information system dealing with genetic information.

Its objectives include:

Protecting national security.

Protecting human life and health.

Establishing sovereignty over the storage and use of genetic data.

Facilitating information exchange between authorised government institutions.

Supporting cooperation with holders of genetic data in connection with genetic-engineering activities.

The law establishes an important institutional arrangement:

InstitutionResponsibility
Russian FederationHolder of information contained in the national system
Ministry of Science and Higher EducationState customer of the information system
Kurchatov InstituteInformation-system operator

Consultant Plus+1

B. Legal significance of governmental control

The National Database establishes a framework for national-level control over genetic information.

For example, where genetic information is generated by scientific institutions or biotechnology research organisations, the statutory system provides a mechanism for information exchange between authorised institutions.

However, three legal concepts must be distinguished:

Governmental control of a national database.

Ownership or control of physical biological samples.

Individual rights concerning personal genetic information.

They are not interchangeable.

The fact that the Russian Federation is designated as the holder of information in the national database does not, by itself, establish that the state owns every person's DNA or biological material.

4. Federal Law No. 242-FZ of 3 December 2008 – State Genomic Registration

This legislation provides the principal framework for state genomic registration in Russia.

It regulates the collection, recording, storage, use, transfer and destruction of biological material and genomic information by authorised institutions.

A. Article 1 – Definition of genomic information

Article 1 defines genomic information as biometric personal data containing coded information concerning certain DNA fragments of an individual or an unidentified deceased person.

It also defines biological material and the federal database of genomic information.

B. Article 2 – Purpose of genomic registration

The principal statutory purpose is identification of individuals.

This is important for:

Criminal investigations.

Identification of unidentified deceased persons.

Identification of missing persons.

Identification of biological relationships in legally recognised circumstances.

Forensic investigations.

C. Collection and storage

The legal framework distinguishes between mandatory and voluntary state genomic registration.

The collection and processing of DNA information must have an appropriate statutory basis.

An institution cannot assume that a person's participation in one DNA examination automatically authorises every subsequent use of that person's genetic information.

D. Destruction and retention

Biological material and genomic information must be managed according to the applicable statutory retention and destruction rules.

These requirements are important because DNA information may reveal highly personal characteristics and biological relationships.

CIS Legislation+2

5. Federal Law No. 152-FZ of 27 July 2006 – Personal Data Protection

The Federal Law on Personal Data is another essential part of Russia's sovereign genomic infrastructure.

Genomic information can identify an individual and may also reveal information about biological relatives.

Consequently, genomic-data processing raises questions concerning:

Lawful collection.

Consent and other legal grounds for processing.

Purpose limitation.

Data security.

Disclosure to third parties.

Retention and deletion.

Individual access and legal remedies.

Important provisions

Article 5 – Principles of personal-data processing

Processing must comply with principles of legality, fairness and purpose limitation.

Article 6 – Conditions of processing

Personal-data processing requires a legally recognised basis.

Article 7 – Confidentiality

Personal-data operators and other persons with access to personal data must maintain confidentiality, subject to statutory exceptions.

Article 18 – Obligations concerning processing

This provision includes requirements relating to the organisation and conditions of personal-data processing.

Article 19 – Security

Operators must take appropriate organisational and technical measures to protect personal information.

Article 21 – Clarification, blocking and destruction

The legislation establishes obligations concerning the correction, blocking and destruction of personal data in specified circumstances.

Article 23 – Supervisory authority

The authorised personal-data supervisory authority is responsible for monitoring compliance with applicable personal-data legislation.

Consultant Plus+1

Practical example:

Suppose a Russian biotechnology company collects DNA samples from 50,000 individuals for a genetic research project.

The company must establish:

The legal basis for collecting the samples.

The purpose of genetic analysis.

The lawful basis for retaining identifiable genetic information.

Security arrangements for its database.

Rules for access by researchers and external organisations.

Procedures for responding to unlawful disclosure.

A general claim that the project supports national scientific development would not, by itself, remove the company's personal-data obligations.

6. Federal Law No. 323-FZ of 21 November 2011 – Medical Confidentiality

The Federal Law on the Fundamentals of Health Protection of Citizens in the Russian Federation is particularly important when genomic infrastructure is connected with hospitals, clinical laboratories, genetic counselling and precision medicine.

Article 13 – Medical confidentiality

Information concerning a patient's medical treatment, health condition, diagnosis and medical examination constitutes medical confidentiality.

Disclosure is generally prohibited without the patient's written consent, except in legally specified circumstances.

These circumstances include certain medical emergencies, infectious-disease situations and legally authorised requests from investigative authorities and courts.

Article 19 – Patient rights

Patients enjoy statutory rights concerning medical assistance and their participation in healthcare decisions.

Article 20 – Informed voluntary consent

Medical intervention generally requires informed voluntary consent, subject to statutory exceptions.

Article 22 – Information concerning health

Patients have the right to receive information about their health, including examination results and diagnoses.

minzdrav.gov.ru+1

Legal application: A hospital that conducts genomic testing must distinguish between consent to medical treatment, consent to scientific research and the legal basis for further processing or disclosure of genomic information.

7. Federal Law No. 86-FZ of 5 July 1996 – Genetic Engineering Regulation

Federal Law No. 86-FZ regulates state activities in the field of genetic engineering.

It is relevant to sovereign genomic infrastructure because genetic engineering research depends on biological resources, genetic information, scientific laboratories and regulated research activities.

Its scope includes the legal regulation of genetically engineered activities and associated safety requirements.

The amendments introduced by Federal Law No. 643-FZ are particularly significant because they expanded the statutory terminology to include genetic information and genetic data and established the National Database framework.

The distinction is important: the national genetic-information database is not simply a criminal DNA identification database. It belongs to a broader genetic-engineering and scientific-information governance framework.

CIS Legislation+1

 

8. Federal Law No. 43-FZ of 20 February 2026 – Restrictions on International Genetic-Data Transfers

Effective 1 September 2026

A significant recent development is Federal Law No. 43-FZ of 20 February 2026, which amended Federal Law No. 86-FZ.

It introduced Article 13.2, dealing specifically with the transfer of human genetic data obtained through population-genetic and/or immunological research.

A. Article 13.2 – Restrictions on transfer

The provision prohibits specified transfers of such genetic data to:

Foreign individuals and legal entities located in Russia.

Representative offices and branches of foreign legal entities in Russia.

Representatives of those foreign entities in Russia.

Individuals and legal entities located outside Russia.

Foreign states.

Exceptions are possible under the statutory procedure.

B. Broad definition of transfer

The law adopts a broad approach. Transfer includes activities involving:

Collection.

Storage.

Providing access.

Transmission.

Distribution.

Publication or placement in information and telecommunications networks.

Other actions that make the relevant genetic data available to the specified recipients.

Consultant Plus+3

C. Exceptions and international scientific cooperation

The legislation provides exceptional routes for certain transfers under Article 13.1.

The statutory framework recognises specified purposes, including:

Medical assistance to a particular patient.

Development and manufacture of medicines or biomedical cellular products for a particular patient.

International cooperation in accordance with Russian legislation.

The relevant government procedures and conditions must also be considered.

ГАРАНТ+1

 

Example:

A Russian population-genetics research institution wants to share genomic datasets with a foreign university.

It cannot assume that an ordinary research agreement or participant consent automatically makes the transfer lawful. It must first determine whether the information falls within Article 13.2 and whether an applicable statutory exception and procedure permit the proposed disclosure.

This legislation makes international genomic research compliance an important element of Russian genomic sovereignty.

9. National Biological Security and Genomic Infrastructure

Sovereign genomic infrastructure also connects with national biological security.

Russia's biological-security framework includes the Presidential Decree No. 97 of 11 March 2019, approving the Fundamentals of State Policy of the Russian Federation in the Field of Chemical and Biological Safety for the Period up to 2025 and Beyond.

Relevant concerns include:

Protection against biological threats.

Monitoring biological risks.

Development of domestic scientific capacity.

Protection of biological resources.

Prevention of unauthorised use of biological materials.

Scientific and technological independence.

The Russian parliamentary commission's 2023 report also addressed genetic-data protection, biomaterial exports and biological-security arrangements.

However, the report is a governmental parliamentary document, not a judicial finding or independent determination of the allegations it contains.

council.gov.ru+1

 

10. Important Case Laws and Judicial Decisions

There is an important research limitation here: Russian courts have not established a comprehensive body of reported decisions specifically governing the National Database of Genetic Information under Article 10.1.

Nevertheless, several European Court of Human Rights decisions concerning Russia provide important legal principles for evaluating genomic infrastructure, particularly privacy, DNA evidence, confidentiality and government access to sensitive information.

Case 1. Kalacheva v. Russia (2009)

DNA evidence and family rights

Citation: Kalacheva v. Russia, Application No. 3451/05, Judgment of 7 May 2009.

Facts:

The applicant sought to establish the paternity of her child.

A DNA examination indicated a 99% probability that the defendant was the child's biological father.

However, the defendant challenged the examination on procedural grounds, and the domestic court rejected the applicant's claim without ordering a second DNA test.

Decision:

The European Court of Human Rights found a violation of Article 8 of the European Convention on Human Rights.

It considered that the domestic authorities had failed to provide an adequate procedure for resolving the biological-parentage dispute.

Legal principles:

DNA evidence can be essential in establishing biological relationships.

Courts must properly evaluate scientific evidence.

Procedural fairness is important when genomic evidence determines family relationships.

Access to reliable genetic testing may be relevant to private and family life.

Relevance to sovereign genomic infrastructure:

A national genomic system must maintain scientific reliability, proper evidence-handling procedures and safeguards against arbitrary rejection or misuse of DNA evidence.

HUDOC+1

Case 2. Avilkina and Others v. Russia (2013)

Medical confidentiality

Citation: Avilkina and Others v. Russia, Application No. 1585/09, Judgment of 6 June 2013.

Facts:

Medical institutions in St Petersburg were instructed to report certain patients' refusals of blood transfusions to prosecutorial authorities.

Medical information concerning two applicants was disclosed to the authorities without their consent.

The applicants challenged the disclosure as an interference with their private lives.

Decision:

The European Court of Human Rights found a violation of Article 8.

The Court emphasised that sensitive medical information requires effective safeguards against unjustified disclosure.

Legal principles:

Medical information is protected by the right to private life.

Government authorities must have a legitimate legal basis for obtaining confidential health information.

Disclosure must be proportionate to the legitimate objective.

Effective safeguards are required against arbitrary access.

Relevance to genomic infrastructure:

Genetic information may reveal considerably more than an ordinary medical record, including inherited conditions and biological relationships.

Therefore, institutions managing national genomic databases should establish strict access controls and confidentiality arrangements.

HUDOC+1

Case 3. Roman Zakharov v. Russia (2015)

Government surveillance and privacy

Citation: Roman Zakharov v. Russia, Application No. 47143/06, Grand Chamber Judgment of 4 December 2015.

Facts:

The applicant challenged the Russian system of secret interception of mobile telephone communications.

The case concerned surveillance capabilities available to law-enforcement authorities and insufficient safeguards against arbitrary interception.

Decision:

The Grand Chamber found a violation of Article 8.

It identified shortcomings in the legal safeguards governing secret surveillance and the availability of effective remedies.

Legal principles:

State surveillance requires a sufficiently clear legal framework.

Access to private information must be controlled.

Safeguards against abuse must be effective.

Independent supervision and effective remedies are important.

Relevance to sovereign genomic infrastructure:

Although the case concerned telecommunications rather than DNA, its reasoning is relevant when evaluating governmental access to national genomic databases.

A state cannot justify unrestricted access to private information merely by referring to national security.

HUDOC+1

Case 4. Y.G. v. Russia (2022)

Confidential information and database security

Citation: Y.G. v. Russia, Application No. 8647/12, Judgment of 30 August 2022.

Facts:

The applicant discovered that a database containing sensitive health information, including information concerning HIV and hepatitis, was being sold at a market.

He alleged that the information had originated from government records and that the authorities had failed to protect it adequately or investigate its disclosure.

Decision:

The European Court of Human Rights found a violation of Article 8.

It held that the authorities had failed to fulfil their positive obligations to protect the applicant's private information and investigate its disclosure effectively.

Legal principles:

Authorities must protect sensitive information against unlawful disclosure.

Database operators require appropriate security arrangements.

Allegations of unlawful disclosure require effective investigation.

State responsibility may arise from failures to protect confidential information.

Relevance to sovereign genomic infrastructure:

The case provides an important analogy for national genetic-information databases.

A government may establish a centralised genomic system for legitimate purposes, but it must also protect that system against unauthorised access, misuse and disclosure.

Concordans+1

Case 5. S. and Marper v. United Kingdom (2008)

Citation: S. and Marper v. United Kingdom, Applications Nos. 30562/04 and 30566/04, Grand Chamber Judgment of 4 December 2008.

Facts:

The applicants challenged the indefinite retention of their fingerprints, cellular samples and DNA profiles after criminal proceedings had ended without convictions.

Decision:

The European Court of Human Rights found a violation of Article 8.

It considered the blanket and indiscriminate retention of the applicants' biometric and biological information disproportionate.

Legal principles:

DNA profiles and biological samples are sensitive personal information.

Retention must have a legitimate purpose.

Indefinite and indiscriminate storage can violate privacy.

Differentiated retention rules and safeguards are important.

Relevance to Russia:

The decision offers comparative guidance for evaluating the retention policies of Russian genomic databases.

It is not a judgment against Russia and does not directly invalidate Russian genomic-registration legislation.

Law Gratis+1

11. Legal Significance of These Cases

CaseMain legal principleApplication to genomic infrastructure
Kalacheva v. Russia (2009)Reliability of DNA evidenceScientific accuracy and procedural fairness
Avilkina v. Russia (2013)Medical confidentialityRestricted access to genetic information
Roman Zakharov v. Russia (2015)Surveillance safeguardsControl of government database access
Y.G. v. Russia (2022)Database securityPrevention of genetic-data leaks
S. and Marper v. UK (2008)Proportionality of DNA retentionLawful retention and deletion policies

Jurisdictional qualification: These European Court of Human Rights decisions remain relevant as historical judgments concerning Russia and as comparative legal authorities. Russia ceased to be a party to the European Convention on Human Rights on 16 September 2022. They should not be described as a currently available Strasbourg remedy for new events occurring after that date.

12. Institutional Structure of Sovereign Genomic Governance in Russia

Several government institutions contribute to the development and regulation of genomic infrastructure.

InstitutionPrincipal responsibility
Ministry of Science and Higher EducationNational scientific and genetic-information policy
Kurchatov InstituteOperation of the National Database of Genetic Information
Ministry of HealthHealthcare, clinical genetics and medical research
Ministry of Internal AffairsRelevant forensic and law-enforcement genomic activities
Investigative CommitteeCriminal investigations involving genetic evidence
RoskomnadzorPersonal-data protection supervision
Federal Security Service (FSB)Relevant national-security functions

Their respective powers arise from different legal instruments. They should not be treated as having unrestricted or interchangeable access to genomic information.

13. Major Legal Challenges

A. Genetic-data sovereignty versus individual privacy

National genomic infrastructure requires the state to manage genetic information for scientific, medical and security purposes.

However, individuals retain legally protected interests in their personal information.

The challenge is to balance public objectives with privacy and dignity.

B. Foreign biotechnology partnerships

International scientific partnerships may involve genetic sequencing, genomic databases and the exchange of biological samples.

Article 13.2 of Federal Law No. 86-FZ creates additional restrictions for genetic data obtained through specified population-genetic and immunological research.

C. Cybersecurity threats

A centralised genomic database creates potential risks involving:

Unauthorised database access.

Genetic-information theft.

Manipulation of research records.

Disclosure of hereditary disease information.

Commercial misuse of genomic datasets.

D. Ownership of biological samples

A further legal challenge concerns the distinction between physical biological material and digital genetic information.

The legal status of a biological sample cannot automatically be determined by the fact that related information appears in a state database.

E. Scientific independence

Russia must also address the legal and institutional challenges associated with developing domestic DNA sequencing, laboratory equipment, biotechnology software and genomic research capabilities.

F. Artificial intelligence and genomic information

AI-assisted genomic analysis raises questions concerning scientific reliability, discrimination, automated decision-making and responsibility for erroneous genetic predictions.

The existing framework should not be interpreted as a complete statutory code for all AI-genomics applications.

14. Liability for Violations

Different forms of legal responsibility may arise when institutions misuse genomic infrastructure.

Legal frameworkPotential violation
Federal Law No. 152-FZUnlawful personal-data processing
Federal Law No. 323-FZBreach of medical confidentiality
Criminal Code Article 137Unlawful collection or dissemination of private-life information
Administrative Code Article 13.11Violations of personal-data legislation
Civil CodeCompensation and other civil remedies
Federal Law No. 86-FZViolations of applicable genetic-engineering and genetic-data transfer requirements

The applicable offence, sanction or remedy depends on the specific conduct and the relevant statutory elements.

15. Hypothetical Legal Case Study

Case: Unauthorised transfer of Russian population-genomic information to a foreign biotechnology company

Suppose a Russian research institution collects genetic information from 20,000 individuals through a population-genetics study.

The institution subsequently provides the dataset to a foreign biotechnology company without following the applicable statutory procedure.

The following legal questions arise:

Does the information qualify as human genetic data under Federal Law No. 86-FZ?

Was it obtained through population-genetic or immunological research?

Does Article 13.2 apply?

Is there an applicable statutory exception?

Were the requirements of Federal Law No. 152-FZ satisfied?

Were the participants' privacy and other legal rights respected?

Does the transfer create administrative, civil or criminal liability?

Possible legal consequences:

Investigation by competent authorities.

Restrictions on unlawful data processing or disclosure.

Administrative sanctions where statutory requirements are met.

Civil claims where legally recognised harm has occurred.

Other statutory consequences depending on the circumstances.

This hypothetical illustrates the relationship between national genomic sovereignty, individual privacy and international biotechnology cooperation.

16. Recommendations for Strengthening Russian Sovereign Genomic Infrastructure

Several legal and institutional measures could improve the framework:

1. Comprehensive genomic legislation: Develop clearer rules covering national genomic databases, biobanks, research institutions and clinical genomic services.

2. Transparent access arrangements: Establish clearly defined authorisation procedures for government officials and researchers.

3. Independent supervision: Strengthen oversight of access, retention and secondary use of genomic information.

4. Data-security standards: Require strong encryption, access logs, cybersecurity testing and incident-response procedures.

5. Research consent: Improve the distinction between consent for medical treatment, genetic research and subsequent data use.

6. International cooperation: Clarify the statutory procedures for lawful international genomic research.

7. Scientific accountability: Establish appropriate standards for genetic testing accuracy, research integrity and AI-assisted genomic analysis.

8. Judicial remedies: Ensure effective mechanisms for challenging unlawful collection, disclosure and retention of genomic information.

17. Conclusion

Biotechnology Sovereign Genomic Infrastructure Law in Russia represents an emerging area of biotechnology, constitutional, administrative, healthcare and information law.

Its principal legislative foundations include:

Federal Law No. 86-FZ of 1996.

Federal Law No. 152-FZ of 2006.

Federal Law No. 242-FZ of 2008.

Federal Law No. 323-FZ of 2011.

Federal Law No. 643-FZ of 2022.

Federal Law No. 43-FZ of 2026.

The National Database of Genetic Information, established under Article 10.1 of Federal Law No. 86-FZ, represents an important institutional mechanism for national control over genetic information.

The introduction of Article 13.2 in September 2026 further strengthens the legal framework governing specified international genetic-data transfers.

The judicial decisions in Kalacheva, Avilkina, Roman Zakharov and Y.G. provide important principles concerning DNA evidence, medical confidentiality, privacy and database security.

Ultimately, the central legal question is how Russia can develop a nationally controlled genomic infrastructure while protecting individual genetic privacy, scientific integrity, lawful research and constitutional rights.

18. Important Legal Sources for Further Research

Federal Law No. 643-FZ – Genetic Engineering and National Genetic Database.

Article 10.1 – National Database of Genetic Information.

Federal Law No. 242-FZ – State Genomic Registration.

Federal Law No. 152-FZ – Personal Data Protection.

Federal Law No. 323-FZ – Health Protection.

Article 13.2 – Human Genetic-Data Transfers.

Avilkina and Others v. Russia.

Roman Zakharov v. Russia.

Kalacheva v. Russia.

Y.G. v. Russia.

Academic note: This is a research-oriented legal explanation, not a substitute for examining the authoritative Russian-language legislation, implementing regulations and complete judicial decisions. The case law cited does not establish that Russian courts have directly adjudicated the entire sovereign genomic infrastructure framework.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT